Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Abstract

The basis for resistance to VEGF inhibition is not fully understood despite its clinical importance. In this study, we examined the adaptive response to VEGF-A inhibition by a loss-of-function analysis using plasmid-based shRNA. Tumor xenografts that initially responded to VEGF-A inhibition underwent an adaptation in vivo, leading to acquired resistance. VEGF-A blockade in tumors was associated with HIF1α expression and an increase in CD144(+) vasculogenic mimicry (VM), leading to formation of channels displaying Tie-1 and MMP-2 upregulation. CD133(+) and CD271(+) melanoma stem-like cells (MSLC) accumulated in the perivascular niche. Tumor xenografts of melanoma cell populations that were intrinsically resistant to VEGF-A blockade did not exhibit any of these features, compared with nontarget control counterparts. Thus, melanomas that are initially sensitive to VEGF-A blockade acquire adaptive resistance by adopting VM as an alternate angiogenic strategy, thereby enriching for deposition of MSLC in the perivascular niche through an HIF1α-dependent process. Conversely, melanomas that are intrinsically resistant to VEGF-A blockade do not show any evidence of compensatory survival mechanisms that promote MSLC accumulation. Our work highlights the potential risk of anti-VEGF treatments owing to a selective pressure for an adaptive resistance mechanism that empowers the development of stem-like cancer cells, with implications for how to design combination therapies that can improve outcomes in patients.

• Authors: Caroline I Schnegg, Moon Hee Yang, Subrata K Ghosh, Mei-Yu Hsu
• Journal: Cancer research (Cancer Res) Vol. 75 Issue 8 Pg. 1682-90 (Apr 15 2015) ISSN: 1538-7445 [Electronic] United States
• PMID: 25769726 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: ©2015 American Association for Cancer Research.

Chemical References

• RNA, Small Interfering
• Vascular Endothelial Growth Factor A

Topics

• Animals
• Cell Count
• Cell Proliferation (drug effects, genetics)
• Drug Resistance, Neoplasm (genetics)
• Gene Expression Regulation, Neoplastic (drug effects)
• Gene Knockdown Techniques
• Humans
• Melanoma (drug therapy, genetics, pathology)
• Mice
• Mice, Inbred C57BL
• Mice, SCID
• Neoplastic Stem Cells (drug effects, pathology)
• Neovascularization, Pathologic (genetics)
• RNA Interference (drug effects)
• RNA, Small Interfering (pharmacology, therapeutic use)
• Skin Neoplasms (drug therapy, genetics, pathology)
• Tumor Cells, Cultured
• Up-Regulation (genetics)
• Vascular Endothelial Growth Factor A (antagonists & inhibitors, genetics)
• Xenograft Model Antitumor Assays